Lucentis for New Onset Neovascular Glaucoma
Stopped Company withdrew funding/sponsorship
Conditions
- Glaucoma
- New Onset Glaucoma
- Neovascular Glaucoma
- New Onset Neovascular Glaucoma
Interventions
- DRUG: Ranibizumab (Lucentis)
Sponsor
University of Illinois at Chicago
Collaborators